MK-383 (Tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor

Platelets

Volumn 13, Issue 3, 2002, Pages 133-140

  Barlage, Stefan ^a   Wimmer, Antonia ^a   Pfeiffer, Alexandra ^a   Rothe, Gregor ^a   Schmitz, Gerd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; TIROFIBAN;

ANTICOAGULATION; ARTICLE; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CONFORMATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN CONFORMATION; TYROSINE;

EID: 0036278681     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09533710022149377     Document Type: Article

References (26)

1. On the structure and function of platelet integrin alphaIIbbeta3, the fibrinogen receptor
2. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex
3. Signaling through platelet integrin alpha IIb beta 3: Inside-out, outside-in, and sideways
4. Integrin signaling: The platelet paradigm
5. New insights into the mechanisms of platelet adhesion and aggregation
6. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
7. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease
8. Effect of platelet activation on the conformation of the plasma membrane glycoprotein [IIb-IIIa complex
9. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852
10. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors
11. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa
12. Application of fluorescence resonance energy transfer in the clinical laboratory: Routine and research
13. Fluorescence resonance energy transfer as a new method for the epitope-specific characterization of anti-platelet antibodies
14. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease
15. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates
16. Complementary roles for receptor clustering and conformational change in the adhesive and signaling functions of integrin alphaIIb beta3
17. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3
18. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin alpha IIb beta 3
19. D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate
20. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation
21. Differential expression of a ligand induced binding site (LIBS) by GpIIb/IIIa ligand recognition peptides and parenteral antagonists
22. Differential antiplatelet effects of various glycoprotein Iib-IIIa antagonists
23. Bidirectional transmembrane modulation of integrin alphaIIbbeta3 conformations
24. 2+ signaling
25. Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses
26. A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3